Radiation Oncology Victoria and Genesis Careare committed to the participation and coordination of clinical trials within its practices.
Genesis CancerCare and Trans-Tasman Radiation Oncology Group Strategic Partnership
The Trans-Tasman Radiation Oncology Group (TROG) is a global leader in radiotherapy research working with over nine hundred researchers and doctors in more than 50 trials involving over 12,000 patient volunteers to help advance cancer treatments. GenesisCare is the leading provider of radiation oncology in Australia undertaking around 320,000 cancer treatments every year and is currently involved in over 40 clinical trials. GenesisCare and TROG will work together to improve patient access to clinical trials and promote innovation in research to deliver better patient outcomes.
The table below details the clinical trials currently recruiting, in the follow up phase and completed. Please click the provided link to go to the public trial register which provides even further information on each of the respective trials.
If you are interested in being involved with any of the active (recruiting) trials please discuss with your Radiation Oncologist at the time of your consultation.
|RECRUITING TRIALS||(patients are being enrolled)|
|*ANZMTG 1-09/**TROG 8.09
|A Randomised Trial of Post-operative Radiation Therapy Following Wide Excision of Neurotropic Melanoma of the Head and Neck||This is a 2-armed randomised controlled trial comparing surgery alone with surgery plus post-operative radiation therapy for patients with completely resected primary melanoma showing histological features of neurotropism.|
|*ANZMTG 1-07/**TROG 8.05
|Whole Brain Radiotherapy following local treatment of melanoma brain metastases||This trial seeks to determine if WBRT reduces the spread of brain metastases and lengthens the time to recurrence. The trial also examines the effect of WBRT on quality of life and brain functions such as memory, speech and concentration. Participants will be randomised after local treatment of their brain metastases to either WBRT or observation.|
|Post-operative Concurrent Chemo-radiotherapy Versus Post-operative Radiotherapy in High-risk Cutaneous Squamous Cell Carcinoma of the Head and Neck||Post-operative Concurrent Chemo-radiotherapy Versus Post-operative Radiotherapy in High-risk Cutaneous Squamous Cell Carcinoma of the Head and Neck|
|FOLLOW UP TRIAL||(recruitment completed, data collection on patients continues)|
|A Phase III International Randomised Trial Of Single Versus Multiple Fractions For Re-Irradiation Of Painful Bone Metastases||This randomised phase III trial is studying single-dose radiation therapy to see if it works as well as multiple-dose radiation therapy in treating patients previously irradiated with painful bone metastases.|
|COMPLETED TRIAL||(data collection & analysis completed)|
|*ANZMTG 1-02/**TROG 2.01
|Randomised Clinical Trial of surgery Versus Surgery Plus Adjuvant Radiotherapy for Regional Control in Patients With Completely Resected Macroscopic Nodal Metastatic Melanoma||This trial seeks to establish the role of post-operative radiotherapy in patients who have had surgery for melanoma involving lymph nodes and who are at high risk of recurrence. This trial has been completed.|
*ANZMTG = Australia New Zealand Melanoma Trials Group
**TROG = Trans Tasman Radiation Oncology Group